Concomitant coronary and renal revascularization improves left ventricular hypertrophy more than coronary stenting alone in patients with ischemic heart and renal disease

Por Dong, Hao-jian, Huang, Cheng, Luo, De-mou, Ye, Jing-guang, Yang, Jun-qing, Li, Guang, Luo, Jian-fang, Zhou, Ying-ling
Publicado no J Zhejiang Univ Sci B (2016)

Decrease of Glomerular Filtration Rate may be Attributed to the Microcirculation Damage in Renal Artery Stenosis

Por Dong, Yao-Jian, Huang, Cheng, Luo, De-Mou, Ye, Jing-Guang, Yang, Jun-Qing, Li, Guang, Luo, Jian-Fang, Zhou, Ying-Ling
Publicado no Chin Med J (Engl) (2015)

Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary In...

Por Liu, Yong, Liu, Yuan-hui, Tan, Ning, Chen, Ji-yan, Zhou, Ying-ling, Li, Li-wen, Duan, Chong-yang, Chen, Ping-Yan, Luo, Jian-fang, Li, Hua-long, Wei-Guo
Publicado em 2014

Targeting myocyte-specific enhancer factor 2D contributes to the suppression of cardiac hypertrophic growth by miR-92b-3p in mice

Por Hu, Zhi-Qin, Luo, Jian-Fang, Yu, Xue-Ju, Zhu, Jie-Ning, Huang, Lei, Yang, Jing, Fu, Yong-Heng, Li, Tao, Xue, Yu-Mei, Feng, Ying-Qing, Shan, Zhi-Xin
Publicado no Oncotarget (2017)